Datavault AI (NASDAQ: DVLT) CEO Nate Bradley will present at a private investor roundtable on April 2, 2026, at The Mar-a-Lago Club in Palm Beach, Florida, marking his second invitation in two months amid growing institutional interest in the company’s data monetization, tokenization and AI-driven platform. The event builds on momentum from a February engagement […]

Forward Industries (NASDAQ: FWDI), a Solana treasury company, recently finished its first full reporting period as the world’s largest Solana treasury. A recent article shares details from an announcement of the company’s fiscal first quarter 2026 operating and financial results, updates, milestones and future plans. “As of Dec. 31, 2025, Forward Industries has SOL holdings […]

U.S. Energy (NASDAQ: USEG) announced the pricing of an underwritten public offering of 8.8 million shares at $1.00 per share for gross proceeds of approximately $8.8 million, with closing expected March 10, 2026, subject to customary conditions. The company said it intends to use net proceeds to fund growth capital for its industrial gas development project, […]

HeartBeam (NASDAQ: BEAT) was featured in a recent article that discussed Joseph Gunnar & Co.’s upgrade of the company from Hold to Buy and raising of its 12-month price target to $4 from $1, citing regulatory progress and the company’s transition toward commercialization. The piece reads, “‘We upgrade HeartBeam to a BUY and High-Risk rating with […]

LIXTE Biotechnology Holdings (NASDAQ: LIXT), a clinical-stage pharmaceutical company, is in the unique position of holding the world’s only clinical-stage protein phosphatase 2A (“PP2A”) inhibitor, called LB-100. The LB-100 compound is a proprietary small-molecule PP2A inhibitor that is designed to target protein phosphatase 2A (“PP2A”), introducing a potential new treatment paradigm aimed at enhancing existing […]

Beeline Holdings (NASDAQ: BLNE) reported fourth-quarter 2025 net revenue of $2.5 million, up 127% year over year, on origination volume of $84.7 million, a 44% increase, as the company continued improving loan economics with a 31% rise in average revenue per loan and an 18% reduction in cost per loan. The company also launched its BeelineEquity platform, closing […]

Datavault AI (NASDAQ: DVLT) announced the closing of a definitive agreement with Coppercore Inc. to digitize and tokenize copper resources through its proprietary blockchain platform, targeting the creation of $100 million or more in Coppercoin(TM) digital tokens. Each token will represent five pounds of in-ground copper with pricing linked to COMEX benchmarks, enabling fractional, liquid […]

A strong and diversified pipeline is often the foundation of long-term success in the biotechnology sector, enabling companies to sustain innovation while advancing multiple therapeutic opportunities. Soligenix (NASDAQ: SNGX) is reinforcing that foundation as its investigational therapy SGX945 receives Promising Innovative Medicine designation in the United Kingdom, a development that highlights both the potential of […]

Soligenix (NASDAQ: SNGX) reported 2025 results highlighting progress across its rare disease pipeline, including advancing its Phase 3 FLASH2 trial of HyBryte(TM) for cutaneous T-cell lymphoma with interim analysis expected in Q2 2026 and top-line results anticipated in the second half of the year. The company also noted regulatory momentum with orphan drug designation for […]

Nutriband (NASDAQ: NTRB) announced it has selected a proposed worldwide brand name for its abuse-deterrent fentanyl transdermal system, with plans to submit the name and product labeling to the FDA and international regulators as well as file for trademark protection. The company said the product, developed using its AVERSA(TM) technology, could become the first abuse-deterrent […]

Cardio Diagnostics Holdings (NASDAQ: CDIO) is an artificial intelligence-powered precision cardiovascular medicine company focused on making cardiovascular disease prevention, detection, and management more accessible, personalized, and precise. The company’s approach is centered on advancing how cardiovascular disease is addressed by moving beyond traditional methods that rely on indirect or generalized indicators. At the core of its […]

SEGG Media (NASDAQ: SEGG, LTRYW) announced the appointments of Daniel Bailey as chief commercial officer and Jack Clarke as chief strategy officer following its Veloce acquisition, as the company advances a 90-day plan focused on integration, execution, and monetization. The new executives bring experience scaling Veloce Media Group and driving global partnerships and revenue growth, with […]